- Home
- PEPG
PEPG
PepGen Inc.
as of 12-03-2025 12:24pm EST
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 317.6M | IPO Year: | 2022 |
| Target Price: | $9.50 | AVG Volume (30 days): | 806.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.88 - $6.85 | Next Earning Date: | 11-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered PEPG Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of PepGen Inc. (PEPG)
Avg Cost/Share
$3.20
Shares
200,000
Total Value
$640,000.00
Owned After
4,955,388
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$3.20
Shares
9,375,000
Total Value
$30,000,000.00
Owned After
18,554,273
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Oxford Science Enterprises plc | PEPG | Other | Sep 30, 2025 | Buy | $3.20 | 200,000 | $640,000.00 | 4,955,388 | |
| RA CAPITAL MANAGEMENT, L.P. | PEPG | Director, 10% Owner | Sep 26, 2025 | Buy | $3.20 | 9,375,000 | $30,000,000.00 | 18,554,273 |
Compare PEPG vs Leading Stocks
See how PEPG stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PEPG PepGen Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.